Overexpressing Gastric Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-01-13
Clinical Trial Update: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 [Phase 2]
Phase 2 clinical trial of RC48-ADC in HER2-overexpressing gastric cancer has completed.